| Literature DB >> 32188084 |
Krishnamoorthy Srikanth1, Seung-Hwan Lee2, Ki-Yong Chung3, Jong-Eun Park1, Gul-Won Jang1, Mi-Rim Park1, Na Yeon Kim1, Tae-Hun Kim1, Han-Ha Chai1, Won Cheoul Park1, Dajeong Lim1.
Abstract
Non-synonymous SNPs and protein coding SNPs within the promoter region of genes (regulatory SNPs) might have a significant effect on carcass traits. Imputed sequence level data of 10,215 Hanwoo bulls, annotated and filtered to include only regulatory SNPs (450,062 SNPs), were used in a genome-wide association study (GWAS) to identify loci associated with backfat thickness (BFT), carcass weight (CWT), eye muscle area (EMA), and marbling score (MS). A total of 15, 176, and 1 SNPs were found to be significantly associated (p < 1.11 × 10-7) with BFT, CWT, and EMA, respectively. The significant loci were BTA4 (CWT), BTA6 (CWT), BTA14 (CWT and EMA), and BTA19 (BFT). BayesR estimated that 1.1%~1.9% of the SNPs contributed to more than 0.01% of the phenotypic variance. So, the GWAS was complemented by a gene-set enrichment (GSEA) and protein-protein interaction network (PPIN) analysis in identifying the pathways affecting carcass traits. At p < 0.005 (~2,261 SNPs), 25 GO and 18 KEGG categories, including calcium signaling, cell proliferation, and folate biosynthesis, were found to be enriched through GSEA. The PPIN analysis showed enrichment for 81 candidate genes involved in various pathways, including the PI3K-AKT, calcium, and FoxO signaling pathways. Our finding provides insight into the effects of regulatory SNPs on carcass traits.Entities:
Keywords: GWAS; Hanwoo; backfat thickness; carcass weight; eye muscle area; gene-set enrichment; imputation; marbling; non-synonymous SNP; pathway analysis
Mesh:
Year: 2020 PMID: 32188084 PMCID: PMC7140899 DOI: 10.3390/genes11030316
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Descriptive summary of phenotype data and results of variance component estimation.
| Traits | Phenotypic Data | Variance Components | ||||||
|---|---|---|---|---|---|---|---|---|
| Mean | SD | Max | Min | CV | σ2 g | σ2 p | h2 | |
| Backfat Thickness (mm) | 14.08 | 4.9 | 43 | 2 | 0.35 | 6.79 | 16.98 | 0.29 |
| Carcass Weight(kg) | 441.22 | 52.7 | 682 | 159 | 0.12 | 660.25 | 1962.58 | 0.25 |
| Eye Muscle Area (cm2) | 95.8 | 12.0 | 155 | 34 | 0.13 | 38.23 | 95.69 | 0.29 |
| Marbling Score (1–9) | 6.1 | 1.9 | 9 | 1 | 0.31 | 1.24 | 2.04 | 0.38 |
σ2 g—additive genetic variance; σ2 p—phenotypic variance; h2—heritability.
Figure 1Phenotypic (upper diagonal) and genetic (lower diagonal) correlation among carcass traits in Hanwoo. The genetic correlation was calculated using bivariate reml in GCTA. The colors represent the strength of the correlation given in the scale next to the plot.
Figure 2Manhattan plots of mapped single nucleotide polymorphism (SNP) markers associating with each trait, where the Y-axis defines the –log10 (p)-value against their respective positions on each chromosome (X-axis).
Top 5 SNPs associated with carcass traits in Hanwoo.
| Trait | SNP_ID | Chr | Position |
| SNP Effect | Gene | Type |
|---|---|---|---|---|---|---|---|
| Backfat | rs109467607 | 19 | 7617020 | 8.89E-11 | 0.0579 | NOG | Promoter |
| Thickness | rs110172746 | 19 | 7617964 | 8.89-11 | 0.0323 | NOG | Promoter |
| rs109749187 | 19 | 7618889 | 8.89E-11 | 0.00256 | NOG | Promoter | |
| rs110056766 | 14 | 7616793 | 1.50E-10 | 0.0354 | NOG | Promoter | |
| rs109266249 | 19 | 7617322 | 1.50E-10 | 0.0311 | NOG | Promoter | |
| Carcass | rs210030313 | 14 | 25052440 | 4.12E-30 | 0.0849 | CHCHD7 | Promoter |
| Weight | rs209809798 | 14 | 26269386 | 1.07E-27 | 0.002 | UBXN2B | Promoter |
| rs210867053 | 14 | 34422595 | 2.82E-16 | 0.0006 | C8orf34 | Promoter | |
| rs210421179 | 14 | 34425147 | 2.82E-16 | 0.001 | C8orf34 | Promoter | |
| rs208243667 | 14 | 23986995 | 2.33E-14 | 0.004 | RP1 | Promoter | |
| Eye Muscle Area | rs210030313 | 14 | 25052440 | 3.54E-08 | 0.4121 | CHCHD7 | Promoter |
| rs209809798 | 14 | 26269386 | 5.00E-07 | 0.06 | UBXN2B | Promoter | |
| rs41734611 | 14 | 29827599 | 3.05E-06 | 0.007 | YTHDF3 | Promoter | |
| rs108943384 | 14 | 29828860 | 3.05E-06 | 0.0097 | YTHDF3 | Promoter | |
| rs110364554 | 14 | 29829523 | 3.05E-06 | 0.0051 | YTHDF3 | Promoter | |
| Marbling Score | Novel | 22 | 11888027 | 8.23E-06 | 8.49E-03 | ACVR2B | Non-synonymous |
| rs109436056 | 20 | 36013931 | 1.08E-05 | 9.17E-03 | EGFLAM | Non-synonymous | |
| rs109353762 | 11 | 30965508 | 1.08E-05 | 5.42E-03 | ENSBTAG00000027015 | Promoter | |
| rs109921982 | 19 | 50470876 | 1.17E-05 | 3.40E-03 | ZNF750 | Promoter | |
| rs109995364 | 11 | 30963318 | 1.27E-05 | 6.31E-03 | ENSBTAG00000027015 | Promoter |
Figure 3(a) Protein–protein interaction network analysis of genes harboring significantly associated SNPs (p < 0.005). Genes that were shared between traits were used for the PPIN analysis. (b) The KEGG pathway-based network analysis of genes within the PPI network.
Proportion of variants in each of the four distributions identified from BayesR analysis.
| Trait | nSNPs |
| Number of SNPs in Mixture Component | |||
|---|---|---|---|---|---|---|
| 0 ×
| 10−4 ×
| 10−3 ×
| 10−3 ×
| |||
| Backfat Thickness | 8085 | 7.02 | 441,977 (98.2) | 7920 (1.76) {5.57} | 157 (0.03) {1.08} | 8 (0.002) {0.37} |
| Carcass Weight | 5050 | 606.40 | 445,011 (98.9) | 4875 (1.08) {298.25} | 148 (0.03) {87.07} | 28 (0.01) {221.21} |
| Eye Muscle Area | 8118 | 43.53 | 441,944 (98.20) | 7927 (1.76) {34.47} | 186 (0.04) {7.93} | 5 (0.001) {1.04} |
| Marbling Score | 8524 | 1.37 | 441,538 (98.11) | 8361 (1.86) {1.15} | 161 (0.04) {0.21} | 2 (0.01) {0.01} |
nSNPs—Number of SNPs; —total genetic variance explained by the SNPs. Values in parenthesis denotes the proportion of SNPs in that particular mixture component. —genetic variance. The sum of squares of the SNP effects for the particular mixture component is given in { } brackets.
Number of significant SNPs identified from the genome-wide association study (GWAS) and the genes that were mapped to traits.
| Traits | No. of Suggestive SNPs | No. of Genes Mapped within 5Kb of Suggestive SNPs |
|---|---|---|
| Backfat Thickness | 2657 | 759 |
| Carcass Weight | 3064 | 731 |
| Eye Muscle Area | 2261 | 626 |
| Marbling Score | 2362 | 628 |
| Background c | 450,062 | 14,267 |
PA—Pathway Analysis. c Background refers to the total number of SNPs used in the GWAS.
Gene Ontology (GO) terms and KEGG pathways significantly enriched using genes associated with traits.
| Trait | Category | Term_ID | Term | Count | % |
| Genes | Fold Enrichment |
|---|---|---|---|---|---|---|---|---|
|
| BP_DIRECT | GO:0045944 | Positive regulation of transcription from RNA polymerase II promoter | 38 | 5.34 | 0.002 | MEF2C, GDF2, NOG, FOXA2, CREM, F2RL1, PRKDC, NUFIP1, FLCN, NR2C2, KDM1A, TCF20, GALR3, HEY2, PKD2, PSIP1, POU4F2, NFATC4, TAF9, SPIC, FGF1, PIK3R1, CYR61, NFATC1, TWIST1, NPAS4, FZD5, DDX5, SREBF2, LPIN3, ACVR2A, ZMIZ2, CAMK1, BMP7, NR5A2, PBX2, ATAD2B, IL2 | 1.71 |
| BP_DIRECT | GO:0031175 | Neuron projection development | 10 | 1.41 | 0.002 | NCAM1, GPRIN1, PTPRM, RAC3, CAMSAP2, STMN4, MAP4, LAMB1, AGER, FRY | 3.62 | |
| BP_DIRECT | GO:0007200 | Phospholipase C-activating G-protein coupled receptor signaling pathway | 7 | 0.98 | 0.007 | C3AR1, PLCE1, LTB4R, GALR3, LTB4R2, HTR1F, F2R | 4.07 | |
| MF_DIRECT | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances | 7 | 0.98 | 0.009 | ABCA10, TAP2, TAP1, ABCB6, ABCA5, ABCA12, ABCG2 | 3.84 | |
| MF_DIRECT | GO:0050840 | Extracellular matrix binding | 5 | 0.70 | 0.009 | DMP1, OLFML2A, THBS1, CYR61, SPP1 | 5.87 | |
| MF_DIRECT | GO:0005509 | Calcium ion binding | 34 | 4.78 | 0.014 | MYL3, SYT2, EFCAB3, MYL10, SYT6, KCNIP4, MMP24, CAMKK2, SMOC2, PLCB4, CD93, EEF2K, TPT1, PKD2, HEG1, THBS1, IHH, PNLIPRP2, CRTAC1, NCALD, CDHR2, MMP16, PCDH7, PKD2L1, CDH12, THBD, CALM, EFHB, RYR3, NOTCH4, PDCD6, LRP4, CASQ2, VLDLR | 1.53 | |
| MF_DIRECT | GO:0031681 | G-protein β-subunit binding | 3 | 0.42 | 0.020 | F2RL1, ARF6, F2R | 12.91 | |
| KEGG_PATHWAY | bta04512 | ECM-receptor interaction | 11 | 1.55 | 0.001 | CD47, SDC1, CD36, ITGA8, COL6A2, ITGA2, LAMB1, THBS1, SV2C, HMMR, SPP1 | 3.56 | |
| KEGG_PATHWAY | bta02010 | ABC transporters | 7 | 0.98 | 0.003 | ABCA10, TAP2, TAP1, ABCB6, ABCA5, ABCA12, ABCG2 | 4.69 | |
| KEGG_PATHWAY | bta03450 | Non-homologous end-joining | 4 | 0.56 | 0.010 | DCLRE1C, PRKDC, NHEJ1, MRE11 | 8.66 | |
| KEGG_PATHWAY | bta04080 | Neuroactive ligand-receptor interaction | 18 | 2.53 | 0.030 | GABRG1, C3AR1, F2RL1, VIPR2, CRHR1, EDNRB, CHRM2, LTB4R, GALR3, P2RY14, AVPR1B, LTB4R2, CNR2, HTR1F, GLP1R, GHR, OPRD1, F2R | 1.73 | |
|
| BP_DIRECT | GO:0042127 | Regulation of cell proliferation | 11 | 1.58 | 0.038 | SGK1, TNFRSF11B, SGK3, TNC, JTB, EGLN3, PKD2, GHRL, TNK1, NDRG1, RPA3 | 2.09 |
| BP_DIRECT | GO:0007155 | Cell adhesion | 12 | 1.72 | 0.047 | IBSP, NOV, PARVG, ITGAL, CD47, OPCML, TNC, SULF1, GP1BA, GRHL2, CTNNA3, SPP1 | 1.92 | |
| MF_DIRECT | GO:0044822 | Poly(A) RNA binding | 45 | 6.46 | 0.010 | YWHAZ, ASS1, GRB2, NOC3L, PRKDC, KNOP1, RPS19BP1, NUFIP2, RPS27, PRR3, RPL7, MAK16, MACF1, DHX37, SND1, NUDT16L1, PSIP1, DHX16, RBM47, RPL12, RPS20, CDC42EP4, TNRC6A, MTERF1, KHDRBS3, MRPS28, ZC3H15, TBL2, TSR1, MAGOH, EFTUD2, PKN2, RPL26, CASC3, NUPL2, RBBP6, FLNB, CMSS1, SRSF2, SYNE1, PTCD3, POP1, DDX31, DNTTIP2, KCTD12 | 1.46 | |
| MF_DIRECT | GO:0005096 | GTPase activator activity | 14 | 2.01 | 0.017 | PREX2, ASAP2, ARHGAP24, RGS22, ARHGAP31, RGS20, RABEP1, ARHGAP42, TBC1D1, CDC42EP4, RAP1GAP2, ARAP2, CDC42EP3, TBC1D20 | 2.09 | |
| MF_DIRECT | GO:0005509 | Calcium ion binding | 31 | 4.45 | 0.029 | NKD1, CLSTN3, EFCAB5, DUOX2, MMP27, MMRN1, ZZEF1, KCNIP4, SMOC2, MACF1, FAT3, CRB2, PLA2G12A, EFCAB1, PKD2, SRR, PLCB2, HPGDS, NCALD, PCDH8, DLL1, PCDH7, SLIT2, PCDH18, ATP2C1, RYR3, NUCB2, SULF1, SCIN, ANXA13, ADGRL4 | 1.48 | |
| KEGG_PATHWAY | bta04151 | PI3K-Akt signaling pathway | 21 | 3.01 | 0.021 | PPP2R1B, FGF6, IBSP, CRTC2, YWHAZ, SGK1, SGK3, GRB2, TNC, PKN2, CDK6, GNG11, NFKB1, GNGT1, LAMA3, MAPK3, PDGFRA, PIK3R5, FGF1, MYC, SPP1 | 1.70 | |
| KEGG_PATHWAY | bta04713 | Circadian entrainment | 9 | 1.29 | 0.021 | GNGT1, ADCY8, GRIA1, RYR3, MAPK3, CACNA1I, GNG11, CACNA1C, PLCB2 | 2.61 | |
| KEGG_PATHWAY | bta04020 | Calcium signaling pathway | 12 | 1.72 | 0.071 | CCKAR, ADRB1, P2RX1, ADCY8, PHKG1, RYR3, CACNA1I, PDGFRA, AVPR1A, PPP3CA, CACNA1C, PLCB2 | 1.78 | |
| KEGG_PATHWAY | bta04110 | Cell cycle | 9 | 1.29 | 0.075 | YWHAZ, RAD21, ANAPC4, BUB1, PRKDC, CDK6, MYC, BUB3, STAG1 | 2.02 | |
|
| BP_DIRECT | GO:0016477 | Cell migration | 11 | 1.82 | 0.006 | CUL3, TNS3, ERG, SDC1, FSCN2, PLCG1, IL12A, SIX2, IL12B, BAMBI, SRMS | 2.79 |
| BP_DIRECT | GO:0042127 | Regulation of cell proliferation | 11 | 1.82 | 0.024 | TNFRSF6B, ITK, SGK2, BIRC7, EGLN3, GHRL, TOPORS, TFAP2C, LGR5, SRMS, NKX2-3 | 2.25 | |
| BP_DIRECT | GO:0008286 | Insulin receptor signaling pathway | 5 | 0.83 | 0.037 | SLC2A8, PDK2, FOXO1, RHOQ, ZNF106 | 3.94 | |
| BP_DIRECT | GO:0006874 | Cellular calcium ion homeostasis | 6 | 0.99 | 0.058 | EDN3, ATP2C2, ATP2C1, PKHD1, CCL8, ATP13A3 | 2.85 | |
| MF_DIRECT | GO:0005524 | ATP binding | 50 | 8.28 | 0.086 | MLH1, SKIV2L2, ACSF2, MTHFD1L, LONP1, PIP5KL1, DDX28, PRKACB, SGK2, MYH3, OLA1, CFTR, LIG4, CDK4, NEK11, CDKL4, MAST3, ATP2C2, ACVR2B, DHX29, ATP2C1, NEK7, XYLB, DNAH9, SPO11, KIT, ITM2B, STK40, VRK3, MAP3K1, ENTPD8, LMTK3, ITK, PDK2, SMCHD1, AK1, TGFBR2, TRIO, ATP1A1, STRADB, ATP13A3, TRANK1, SMC4, TP53RK, TEX14, PLK2, PSMC3, MYO16, FPGS, SRMS | 1.23 | |
| MF_DIRECT | GO:0005509 | Calcium ion binding | 26 | 4.30 | 0.089 | LALBA, GPD2, LPO, MYL2, EFCAB5, CRTAC1, PAMR1, PCDH10, CDHR3, SYT9, SYT6, PCDH8, STAB2, LPCAT2, SLIT1, ZZEF1, HMCN2, CDH12, ANXA6, EGFLAM, CLGN, FAT3, PLCG1, ATP2C1, FAT1, MCFD2 | 1.38 | |
| KEGG_PATHWAY | bta04060 | Cytokine-cytokine receptor interaction | 17 | 2.81 | 0.000 | TNFRSF6B, TGFBR2, CCL8, IL10, IL12RB2, CCR9, ACVR2B, IL17B, IL12RB1, PRLR, CCR4, IL12A, TNFRSF19, CSF3R, IL12B, IFNGR2 | 2.83 | |
| KEGG_PATHWAY | bta05200 | Pathways in cancer | 22 | 3.64 | 0.003 | RALBP1, TGFBR2, BIRC7, EGLN3, MLH1, FOXO1, LEF1, ITGA3, NFKB2, KIT, CDK4, MMP2, AGTR1, EDNRB, CUL2, PLCG1, SOS1, RALB, CSF3R, HHIP, PRKACB, TRAF6 | 2.00 | |
| KEGG_PATHWAY | bta00280 | Valine, leucine and isoleucine degradation | 5 | 0.83 | 0.047 | HMGCS2, OXCT1, DLD, IL4I1, ACAD8 | 3.62 | |
| KEGG_PATHWAY | bta00790 | Folate biosynthesis | 3 | 0.50 | 0.048 | GGH, FPGS, GCH1 | 8.37 | |
| KEGG_PATHWAY | bta00564 | Glycerophospholipid metabolism | 7 | 1.16 | 0.050 | GPD2, CHKA, ADPRM, ETNK1, LPCAT2, PLPP1, PLPP2 | 2.61 | |
| KEGG_PATHWAY | bta05231 | Choline metabolism | 7 | 1.16 | 0.054 | CHKA, PLCG1, SOS1, SLC22A5, PLPP1, PLPP2, SLC22A1 | 2.56 | |
| KEGG_PATHWAY | bta04630 | Jak-STAT signaling pathway | 9 | 1.49 | 0.055 | IL12RB2, IL12RB1, PRLR, SOS1, IL12A, CSF3R, IL12B, IFNGR2, IL10 | 2.16 | |
|
| BP_DIRECT | GO:0031663 | Lipopolysaccharide-mediated signaling pathway | 4 | 0.34 | 0.057 | MAPK3, NFKBIA, PRKCE, PTAFR | 4.52 |
| BP_DIRECT | GO:0001568 | Blood vessel development | 4 | 0.34 | 0.057 | MEF2C, PSEN1, ITGAV, RAPGEF2 | 4.52 | |
| BP_DIRECT | GO:0042127 | Regulation of cell proliferation | 9 | 0.77 | 0.090 | SGK1, PTGS2, TNC, LCK, CHST11, NFKBIA, FAS, PLAU, TEC | 1.95 | |
| BP_DIRECT | GO:0007155 | Cell adhesion | 10 | 0.85 | 0.096 | ITGAL, LYVE1, TNC, NPHS1, ACAN, ITGA2, GP1BA, PRKCE, FN1, MYH10 | 1.83 | |
| MF_DIRECT | GO:0008168 | Methyltransferase activity | 6 | 0.51 | 0.004 | ZCCHC4, METTL21B, TRMT10A, PRMT9, NSUN3, METTL18 | 5.52 | |
| MF_DIRECT | GO:0005524 | ATP binding | 54 | 4.61 | 0.013 | KIF22, SEPHS2, INO80, IARS2, PIP5KL1, MOS, PRKACB, SIK2, ABCE1, SGK1, MYH3, CDK6, LIG4, PRKCE, UBE2C, CDK4, CDKL4, UBE2N, MAST4, UBE2K, ATP2C1, RIPK1, LCK, MAPK3, RRM1, DNAH9, PEAK1, PRKDC, CHEK2, ITM2B, DNAH5, STK40, ENTPD8, STK38L, ABCA13, AATK, TEC, DHX8, PDK2, ALPK3, AK1, AK7, RIMKLB, TP53RK, GLYCTK, DYRK1A, ATP2A1, DGKZ, ABCC2, NLRP13, FPGS, KATNAL2, MYH10, ATAD2B | 1.38 | |
| MF_DIRECT | GO:0005509 | Calcium ion binding | 29 | 2.47 | 0.016 | GALNT3, TBC1D9, MMP8, MMP27, C2CD4D, EDIL3, KCNIP1, CRB2, ACAN, CDH26, HPGDS, GPD2, NOX5, ADGRE3, HSPG2, S100A10, STIM1, TC2N, CABYR, CLGN, CDH17, ATP2C1, ATP2A1, DSC3, RYR2, DSC2, ANXA13, SGCA, LCP1 | 1.59 | |
| KEGG_PATHWAY | bta04110 | Cell cycle | 11 | 0.94 | 0.005 | E2F2, YWHAH, HDAC1, RBL1, ANAPC4, PRKDC, CDK6, ANAPC10, ORC6, CHEK2, CDK4 | 2.89 | |
| KEGG_PATHWAY | bta04115 | p53 signaling pathway | 7 | 0.60 | 0.020 | RFWD2, CASP3, CDK6, CHEK2, FAS, CDK4, CCNG1 | 3.24 | |
| KEGG_PATHWAY | bta04514 | Cell adhesion molecules (CAMs) | 10 | 0.85 | 0.044 | GLG1, CLDN8, ITGAL, CLDN18, CD86, VTCN1, ITGAV, CD274, NEO1, CLDN25 | 2.13 |